Growth Factor Delivery is a critical aspect of regenerative medicine and tissue engineering, aiming to harness the therapeutic potential of growth factors for promoting tissue repair, regeneration, and healing. Growth factors are signalling molecules that regulate various cellular processes, including cell proliferation, differentiation, migration, and survival, making them potent mediators of tissue development and repair. Biomaterial-based delivery systems can be engineered to control the release kinetics of growth factors, allowing for precise modulation of their bioavailability and activity within the target tissue. By tuning parameters such as material composition, structure, porosity, and degradation rate, researchers can design delivery systems that release growth factors in response to specific physiological cues. Another strategy for growth factor delivery involves the use of gene therapy techniques to introduce genes encoding growth factors directly into target cells or tissues. This approach allows for sustained production and secretion of growth factors by genetically modified cells, offering prolonged and localized delivery without the need for exogenous protein administration. Furthermore, growth factor delivery can be enhanced through the use of cell-based delivery systems, where growth factor-secreting cells, such as stem cells, fibroblasts, or genetically engineered cells, are implanted or injected into the target tissue. These cells can continuously produce and release growth factors in response to local micro environmental cues, promoting tissue regeneration and repair.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States